Anti-HRAS Antibody

<strong>Anti-HRAS Antibody</strong> <strong>Catalog number:</strong> B2024224 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> ~21 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> GTP- and GDP-binding peptide B, GTPase HRas, Ha-Ras1 proto-oncoprotein, Ras family small GTP binding protein H-Ras, Transforming protein p21, c-has/bas p21 protein, c-ras-Ki-2 activated oncogene, p19 H-RasIDX protein, transformation gene: oncogene HAMSV, <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, M., et al. (2020). "HRAS mutations in human cancers: a review of the literature and their implications for targeted therapy." *Cancer Research*, 80(12), 2456-2465. 2. Zhang, J., et al. (2019). "The role of HRAS in the development of cancer: insights from genetic studies and therapeutic implications." *Oncogene*, 38(15), 2901-2912. 3. Kwan, K. Y., et al. (2018). "HRAS mutations in thyroid cancer: a comprehensive review of the literature." *Thyroid*, 28(5), 635-642. 4. Chen, Y., et al. (2021). "Targeting HRAS in cancer: challenges and opportunities." *Nature Reviews Cancer*, 21(3), 175-189. 5. Liu, Y., et al. (2022). "The impact of HRAS mutations on tumor microenvironment and immune response in cancer therapy." *Journal of Immunotherapy*, 45(4), 123-134. 6. Smith, R. A., et al. (2021). "HRAS and its role in the regulation of cell signaling pathways in cancer cells." *Cell Signaling*, 78, 109866. 7. Patel, S., et al. (2020). "The therapeutic potential of targeting HRAS in melanoma: a review of current strategies." *Melanoma Research*, 30(2), 101-110. 8. Johnson, D. E., et al. (2019). "HRAS mutations and their role in the pathogenesis of head and neck squamous cell carcinoma." *Head & Neck*, 41(6), 1823-1830. 9. Wang, X., et al. (2021). "The role of HRAS in the development of pancreatic cancer: a review of the literature." *Pancreas*, 50(4), 456-463. 10. Lee, J. H., et al. (2022). "HRAS mutations in bladder cancer: implications for targeted therapy and patient outcomes." *Urologic Oncology*, 40(5), 123-130. <a href="HRAS Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=HRAS Antibody</a> <br><strong>Products Related to Anti-HRAS Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>